ARGOS THERAPEUTICS INC's ticker is ARGSXXXX and the CUSIP is 040221103. A total of 26 filers reported holding ARGOS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $0 | – | 1 | -97.9% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 47 | -99.7% | 0.00% | – |
| Q4 2016 | $71,000 | +1083.3% | 14,510 | +1126.5% | 0.00% | – |
| Q3 2016 | $6,000 | -14.3% | 1,183 | +10.0% | 0.00% | – |
| Q2 2016 | $7,000 | – | 1,075 | +21400.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 5 | -96.8% | 0.00% | – |
| Q3 2015 | $1,000 | – | 154 | +862.5% | 0.00% | – |
| Q2 2015 | $0 | – | 16 | -11.1% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 18 | -89.5% | 0.00% | – |
| Q4 2014 | $2,000 | -93.9% | 171 | -95.8% | 0.00% | – |
| Q2 2014 | $33,000 | – | 4,113 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pharmstandard International S.A. | 13,242,279 | $5,984,000 | 15.97% |
| Pharmstandard International S.A. | 5,120,604 | $2,314,000 | 6.17% |
| SANDERS MORRIS HARRIS LLC | 290,424 | $132,000 | 0.02% |
| WEDBUSH SECURITIES INC | 63,500 | $29,000 | 0.00% |
| Virtu KCG Holdings LLC | 127,073 | $57,000 | 0.00% |
| Alyeska Investment Group, L.P. | 200,000 | $90,000 | 0.00% |
| WASATCH ADVISORS LP | 186,900 | $85,000 | 0.00% |
| STATE STREET CORP | 184,194 | $82,000 | 0.00% |
| SG Americas Securities, LLC | 17,652 | $8,000 | 0.00% |
| MEEDER ASSET MANAGEMENT INC | 398 | $0 | 0.00% |